Shashikant Kulkarni's most recent trade in Neogenomics Inc. was a trade of 3,759 Common Stock done . Disclosure was reported to the exchange on April 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Shashikant Kulkarni | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Apr 2023 | 3,759 | 82,673 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Shashikant Kulkarni | President of Lab Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 51,653 | 51,653 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Shashikant Kulkarni | President of Lab Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 24,704 | 65,856 (0%) | 0% | 0 | Common Stock |